We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Strongyloides stercoralis is a parasite that lives in the gut of infected people. It can be fatal in people with immune deficiency
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (29 January 2024) approved the medicine Rezzayo (rezafungin) to treat a fungal infection called invasive candidiasis.
Accord Healthcare Ltd, UK has informed the MHRA about an error with the Patient Information Leaflets (PILs) that have been packaged in the batches of these products mentioned in this notification.
Details of the efficacy and toxicity tests oil spill treatment products must have before being approved for use in UK waters.
Product Safety Report for Caring Chemistry Body Treat Maxitoner presenting a serious chemical risk.
The Minister for Food, Farming and Fisheries grants conditional emergency authorisation to use a product containing a neonicotinoid to treat seeds for the 2024 sugar beet seed crop in England.
A phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
With an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India
Product Safety Report for Body Treat Maxitoner Skin Beautifying Milk presenting a serious chemical risk due to the presence of the chemicals hydroquinone, methylchloroisothiazolinone and methylisothiazolinone (MCI/MI).
This fact sheet aims to raise awareness about zinc, a new treatment for diarrhea
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).